PTGS1 and neoplasm: However, it seems clear that the analysis of functional implications of COX-1-signaling, as well as of the pharmacological action of COX-1-selective inhibitors, should not be restricted to the COX pathway, and to the effects of prostaglandins that are already known for their ability to affect the tumor phenotype.